Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-05-14Clinical Trial Update: CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids [Phase 2]
A Phase 2 trial of CYT003 in patients with mild-to-moderate allergic asthma not adequately controlled on inhaled corticosteroids has been wi…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma [Phase 2]
This update reports the termination of a Phase 2 study of CYT003-QbG10, a TLR9 agonist, for treatment of uncontrolled moderate to severe all…
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma [Phase 2]
A Phase 2 clinical trial evaluating montelukast for treating mild-to-moderate acute asthma in children has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: AeroEclipse II Agreement [Phase 4]
A Phase 4 clinical trial involving AeroEclipse II for asthma has completed, as reported in this update.
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Home-Based Asthma Support and Education for Adults [NA]
A completed clinical trial evaluating home-based asthma support and education for adults. Sponsored by Public Health - Seattle and King Coun…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2014-05-09FDA Approved: ATROVENT HFA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ATROVENT HFA (ipratropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc., reflecti…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study [Phase 4]
Phase 4 pilot study assessing the involvement of small airways in smokers with asthma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma [Phase 2]
A Phase 2 study comparing different doses of olodaterol delivered via the Respimat inhaler in patients with moderate to severe asthma has co…
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma [Phase 2]
This clinical trial update reports Phase 2 results on the safety and effectiveness of JNJ-39758979 in adults with persistent asthma.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of a single-dose orally inhaled DNAzyme solution for nebulisation in adu…
-
FDA approval · 2014-04-25FDA Approved: ASMANEX HFA — Original Application (Organon LLC)
FDA approved the original application for ASMANEX HFA (mometasone furoate) from Organon LLC. The inhaled corticosteroid is used for the main…
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Effectiveness of Osteopathic Manipulative Treatment in Pediatric Asthma [NA]
This clinical trial update reports on the effectiveness of osteopathic manipulative treatment for pediatric asthma; the current status is un…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of single and repeat doses of RV1729 in individuals with asthma an…
-
FDA approval · 2014-04-22FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for ALVESCO (ciclesonide) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: AMG 761 in Adults With Asthma [Phase 1]
Phase 1 study of AMG 761 in adults with asthma was terminated; the trial status is TERMINATED, and no results are provided in the snippet.
-
FDA approval · 2014-04-17FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate and formoterol fumarate dihydrate) from Organon LLC, indicating a lab…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial
An ancillary pharmacogenetic study within the LoDo trial investigates how leukotriene polymorphisms influence montelukast response in asthma…
-
CLINICAL_TRIALS research · 2014-04-15Clinical Trial Update: Novel Gentic Variations Contributing to Asthma Susceptability in Saudi Arabia
This clinical trial update reports the completion of a King Saud University study that aims to build a data bank for asthma in Saudi Arabia …
-
FDA approval · 2014-04-14FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair Diskus (fluticasone propionate and salmeterol) from GlaxoSmithKline.
-
FDA approval · 2014-04-14FDA Approved: SEREVENT DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for SEREVENT DISKUS (salmeterol xinafoate) from GlaxoSmithKline LLC. The approval updates or exp…
-
FDA approval · 2014-04-14FDA Approved: FLUTICASONE PROPIONATE DISKUS — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application to allow Prasco Laboratories to market Fluticasone Propionate Diskus.
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma
A completed study comparing fractional exhaled nitric oxide testing with methacholine challenge for evaluating patients with suspected but u…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Computer-Based Decision Support in Managing Asthma in Primary Care [NA]
McGill University's clinical trial evaluating a computer-based decision-support tool for managing asthma in primary care has completed.
-
FDA approval · 2014-04-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited under an ANDA.
-
FDA approval · 2014-04-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, granting generic approval under ANDA 20…